Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 4, 2015, Pages 342-351

  Sundin, J ^a   Rangel, I ^a   Fuentes, S ^b   Heikamp De Jong, I ^b   Hultgren Hornquist E ^a   De Vos, W M ^b,c   Brummer, R J ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CD8 ANTIGEN; RNA 16S;

ADULT; AMPLICON; ARTICLE; BACTEROIDETES; CLINICAL ARTICLE; CLOSTRIDIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; FECES MICROFLORA; FEMALE; FIRMICUTES; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMMUNOPATHOGENESIS; INTRAEPITHELIAL LYMPHOCYTE; IRRITABLE COLON; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MICROARRAY ANALYSIS; MICROBIAL DIVERSITY; MICROFLORA; MUCOSA CELL; MUCOSAL IMMUNITY; MUCOSAL LYMPHOCYE; MUCOSAL MICROBIOTA; NONHUMAN; PHENOTYPE; PHYLOGENY; POPULATION ABUNDANCE; POST INFECTIOUS IRRITABLE BOWEL SYNDROME; PRINCIPAL COORDINATE ANALYSIS; REDUNDANCY ANALYSIS; SPECIES COMPOSITION; SPECIES RICHNESS; BODY MASS; COMPLICATION; FECES; GASTRITIS; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; BODY MASS INDEX; FECES; FEMALE; GASTRITIS; HUMANS; INTESTINAL MUCOSA; INTESTINES; IRRITABLE BOWEL SYNDROME; LYMPHOCYTE SUBSETS; MALE; MICROBIOTA; MIDDLE AGED; PHENOTYPE; RNA, RIBOSOMAL, 16S;

EID: 84921438829     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13055     Document Type: Article

References (34)

1. Quigley EM, Abdel-Hamid H, Barbara G, et al,. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012; 46: 356-66.
2. Spiller R, Garsed K,. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
3. Rigsbee L, Agans R, Shankar V, et al,. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2012; 107: 1740-51.
4. Rajilic-Stojanovic M, Biagi E, Heilig HG, et al,. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-801.
5. Saulnier DM, Riehle K, Mistretta TA, et al,. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-91.
6. Jalanka-Tuovinen J, Salojärvi J, Salonen A, et al,. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2013; 63: 1737-45.
7. Carroll IM, Ringel-Kulka T, Siddle JP, et al,. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24: 521-30.
8. Goral V, Kucukoner M, Buyukbayram H,. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome. Hepatogastroenterology 2010; 57: 751-4.
9. Lee KJ, Kim YB, Kim JH, et al,. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23: 1689-94.
10. Sundin J, Rangel I, Kumawat AK, et al,. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious IBS patients. Scand J Gastroenterol 2014; 49: 1068-75.
11. Spiller RC, Jenkins D, Thornley JP, et al,. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
12. Zoetendal EG, von Wright A, Vilpponen-Salmela T, et al,. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68: 3401-7.
13. Spiller RC,. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004; 18: 641-61.
14. Gustavsson A, Magnuson A, Blomberg B, et al,. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease. Aliment Pharmacol Ther 2012; 36: 151-8.
15. Salonen A, Nikkilä J, Jalanka-Tuovinen J, et al,. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 2010; 81: 127-34.
16. Rajilic-Stojanovic M, Heilig HG, Molenaar D, et al,. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009; 11: 1736-51.
17. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
18. Longstreth GF, Thompson WG, Chey WD, et al,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
19. ter Braak CJF, Šmilauer P,. Canoco Reference Manual and Users's Guide: Sofware for Ordination (version 5.0). Ithaca, NY, USA: Microcomputer Power, 2012.
20. Simpson E,. Measurement of diversity. Nature 1949; 13: 688.
21. Durbán A, Abellán JJ, Jiménez-Hernández N, et al,. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep 2012; 4: 242-7.
22. Aziz Q, Doré J, Emmanuel A, et al,. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013; 25: 4-15.
23. MacDonald TT, Monteleone I, Fantini MC, et al,. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011; 140: 1768-75.
24. Hermes G, Zoetendal E, Smidt H,. Molecular ecological tools to decipher the role of our microbial mass in obesity. Benef Microbes 2014; 5: 1-21. [Epub ahead of print]
25. Hamer HM, Jonkers D, Venema K, et al,. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
26. Vanhoutvin SA, Troost FJ, Kilkens TO, et al,. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 2009; 21: 952-e76.
27. Walker AW, Ince J, Duncan SH, et al,. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5: 220-30.
28. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al,. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
29. Salter SJ, Cox MJ, Turek EM, et al,. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014; 12: 87.
30. Harrell L, Wang Y, Antonopoulos D, et al,. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS ONE 2012; 7: e32545.
31. Wells JM, Rossi O, Meijerink M, et al,. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1): 4607-14.
32. Fond G, Loundou A, Hamdani N, et al,. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014; 264: 651-60.
33. Cryan JF, Dinan TG,. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-12.
34. Jeffery IB, O'Toole PW, Öhman L, et al,. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006.